These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22827236)

  • 1. Vaccines for hantaviruses: progress and issues.
    Schmaljohn CS
    Expert Rev Vaccines; 2012 May; 11(5):511-3. PubMed ID: 22827236
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccines for hantaviruses.
    Schmaljohn C
    Vaccine; 2009 Nov; 27 Suppl 4():D61-4. PubMed ID: 19837289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hantaviruses: immunology, treatment, and prevention.
    Maes P; Clement J; Gavrilovskaya I; Van Ranst M
    Viral Immunol; 2004; 17(4):481-97. PubMed ID: 15671746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hantaviruses: an emerging threat to human health?
    Bonn D
    Lancet; 1998 Sep; 352(9131):886. PubMed ID: 9742991
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardiopulmonary syndrome in hantavirus infection (an overview)].
    Mukhetdinova GA; Fazlyeva RM; Fazlyev MM
    Voen Med Zh; 2012 Jun; 333(6):47-51. PubMed ID: 22888702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hantavirus immunology.
    Khaiboullina SF; St Jeor SC
    Viral Immunol; 2002; 15(4):609-25. PubMed ID: 12513931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virology. Finally, a handle on the hantaviruses.
    Enserink M
    Science; 2001 Aug; 293(5534):1414-5. PubMed ID: 11520958
    [No Abstract]   [Full Text] [Related]  

  • 8. Hantavirus protein interactions regulate cellular functions and signaling responses.
    Klingström J; Ahlm C
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):33-47. PubMed ID: 21171876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses.
    de Carvalho Nicacio C; Gonzalez Della Valle M; Padula P; Björling E; Plyusnin A; Lundkvist A
    J Virol; 2002 Jul; 76(13):6669-77. PubMed ID: 12050380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective Effectiveness of Inactivated Hantavirus Vaccine Against Hemorrhagic Fever With Renal Syndrome.
    Jung J; Ko SJ; Oh HS; Moon SM; Song JW; Huh K
    J Infect Dis; 2018 Apr; 217(9):1417-1420. PubMed ID: 29373686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic fever with renal syndrome.
    Terajima M; Ennis FA
    Viruses; 2011 Jul; 3(7):1059-73. PubMed ID: 21994770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
    Hooper JW; Josleyn M; Ballantyne J; Brocato R
    Vaccine; 2013 Sep; 31(40):4314-21. PubMed ID: 23892100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term persistence of anti-hantavirus antibodies in sera of patients undergoing hemorrhagic fever with renal syndrome and subjects vaccinated against the disease.
    Zheng Y; Wei J; Zhou BY; Xu Y; Dong JH; Guan LY; Ma P; Yu PB; Wang JJ
    Infect Dis (Lond); 2016 Apr; 48(4):262-266. PubMed ID: 26654580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of ELISA on the basis of monoclonal antibodies for detecting specific activity of the vaccine against hemorrhagic fever with renal syndrome].
    Dzagurova TK; Solopova ON; Sveshnikov PG; Korotina NA; Balovneva MV; Leonovich OA; Varlamov NE; Malkin GA; Sotskova SE; Tkachenko EA
    Vopr Virusol; 2013; 58(1):40-4. PubMed ID: 23785761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis.
    Hjelle B; Jenison S; Torrez-Martinez N; Herring B; Quan S; Polito A; Pichuantes S; Yamada T; Morris C; Elgh F; Lee HW; Artsob H; Dinello R
    J Clin Microbiol; 1997 Mar; 35(3):600-8. PubMed ID: 9041397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses to inactivated vaccine in people naturally infected with hantaviruses.
    Lu Q; Zhu Z; Weng J
    J Med Virol; 1996 Aug; 49(4):333-5. PubMed ID: 8877768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic Cells (DCs) as "Fire Accelerants" of Hantaviral Pathogenesis.
    Schönrich G; Raftery MJ
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31540199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress on the Prevention and Treatment of Hantavirus Disease.
    Brocato RL; Hooper JW
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31277410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Actual problems of hemorrhagic fever with renal syndrome].
    Tkachenko EA; bernshtein AD; Dzagurova TK; Morozov VG; Slonova RA; Ivanov LI; Trankvilevskiĭ DV; Kruger D
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (1):51-8. PubMed ID: 23805652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hantaviruses: a global disease problem.
    Schmaljohn C; Hjelle B
    Emerg Infect Dis; 1997; 3(2):95-104. PubMed ID: 9204290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.